Alzheimer's Disease - myDSC

General DS Info

General DS Information

New Lumind CEO Focuses on Research as a Key to Independence: Part I of III

Introduction to LuMind CEO Hampus Hillerstrom From left: Hampus, Sebastian, Oskar, and Lianor. His Fate,…

Capetivate capetivateJuly 18, 2020

Alzheimers Dementia

Health and Research – Alzheimer's/Dementia

Alzheimer’s in Down syndrome: Status Update and Hope for Progress in Years Ahead

Learn about Alzheimer's Disease in Down syndrome and today's clinical trials with promising therapies. Source:…

Capetivate capetivateJuly 18, 2020

General DS Info

General DS Information

Clinical Trial Volunteers Give The Gift That Keeps On Giving

Dr James Hendrix, LuMind IDSC's Chief Scientific Officer, shares a holiday message about the importance…

Capetivate capetivateJuly 18, 2020

General DS Info

General DS Information

Cerveau Technologies, Inc. Announces Partnership with LuMind IDSC to Expand LIFE-DSR Study

Announcement of Cerveau Technologies' involvement in the LIFE-DSR study organized by LuMind's Down Syndrome Clinical…

Capetivate capetivateJuly 18, 2020

Alzheimers Dementia

Health and Research – Alzheimer's/Dementia

LIFE-DSR – A National Launch for the Natural History Study in Adults with Down Syndrome

A discussion of the launch of LuMind's LIFE-DSR initiative studying Alzheimer's in adults with Down…

Capetivate capetivateJuly 17, 2020

General DS Info

General DS Information Health and Research – Alzheimer's/Dementia

Every Minute Counts: PBS Feature About Alzheimer’s in the US

If you haven’t seen Every Minute Counts, the PBS documentary about Alzheimer’s disease in the…

Capetivate capetivateJuly 17, 2020

Alzheimers Dementia

Health and Research – Alzheimer's/Dementia

Biogen Announces New Hope for Alzheimer’s Drug Candidate Aducanumab

On October 22, 2019, the biopharmaceutical company, Biogen, announced that they will be going to…

Capetivate capetivateJuly 14, 2020

© 2024 myDSC.